Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).

Takuya AwataAkira ShimadaTaro MaruyamaYoichi OikawaNobuyuki YasukawaSusumu KuriharaYumi MiyashitaMasako HatanoYuichi IkegamiMasafumi MatsudaMasataka NiwaYouichiro KazamaShoichiro TanakaTetsuro Kobayashi

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)

Japanese Clinical Trials Registry UMIN000003693.

Keyphrases

type diabetes
clinical trial
double blind
phase ii
open label
phase iii
glycemic control
placebo controlled
multiple sclerosis
insulin resistance
cardiovascular disease
metabolic syndrome